A novel approach applying a chemical biology strategy in phenotypic screening reveals pathway-selective regulators of histone 3 K27 tri-methylation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel approach applying a chemical biology strategy in phenotypic screening reveals pathway-selective regulators of histone 3 K27 tri-methylation
Authors
Keywords
-
Journal
Molecular BioSystems
Volume 10, Issue 2, Pages 251-257
Publisher
Royal Society of Chemistry (RSC)
Online
2013-11-01
DOI
10.1039/c3mb70413k
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell-based systems to assess nuclear receptor activation and their use in drug development
- (2013) Judy L. Raucy et al. DRUG METABOLISM REVIEWS
- The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming
- (2012) Abed AlFatah Mansour et al. NATURE
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
- (2012) M. T. McCabe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phenotype-based high-content chemical library screening identifies statins as inhibitors of in vivo lymphangiogenesis
- (2012) M. M. P. Schulz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair
- (2011) E. Ezhkova et al. GENES & DEVELOPMENT
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- How were new medicines discovered?
- (2011) David C. Swinney et al. NATURE REVIEWS DRUG DISCOVERY
- MEK–ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes
- (2011) S Fujii et al. ONCOGENE
- A Cell-Based High-Content Screening Assay Reveals Activators and Inhibitors of Cancer Cell Invasion
- (2011) M. Quintavalle et al. Science Signaling
- Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
- (2010) D. B. Yap et al. BLOOD
- Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma
- (2010) Adam D. Toll et al. HUMAN PATHOLOGY
- Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
- (2010) C. J. Sneeringer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
- (2009) Gijs van Haaften et al. NATURE GENETICS
- Discovery of Novel Targets with High Throughput RNA Interference Screening
- (2008) Paul Kassner COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started